Skip to content

AtheroNova Inc.

company.status.inactive

CIK 1377053fmd_0D19D1N22Q29QGS2YTVDZNCQQEManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2008 to Sep 30, 2014, 22 periods

Income Statement · Annual · Millions · USD
Line itemFY2008FY2009FY2010FY2011FY2012FY2013
Total revenues––0000
Research and development––0012
Selling, general and administrative––2233
Operating income–––(3)(4)–
Interest expense––0111
Other non-operating income (expense)––(13)71(1)
Income before taxes––(16)4(3)(8)
Income tax expense––0000
Net income from continuing operations––(3)(3)(4)(7)
Net income(0)(0)(16)4(3)(8)